Citations

Mayo Clinic

Showing 10 of 108523 citations.

Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome
Patnaik, Mrinal M. , Wassie, Emnet A, Hanson, Curtis A. , Ketterling, Rhett P. , Tefferi, Ayalew , Lasho, Terra L. , Ketterling, Rhett P

American Journal of Hematology | January 31, 2015 | Volume: 90 | Issue: 5 | Pages: 411-416

10.1002/ajh.23962 | PMID 25645147 Get It

Among 274 patients with chronic myelomonocytic leukemia (CMML) and followed for a median of 17.1 months, blast transformation (BT) occurred in 36 (13%). On multivariable analysis, risk factors for BT were presence of circulating blasts (HR 5.7; 95% CI 2.8–11.9) and female gender (HR 2.6; 95% CI 1.3–5.1); the results remained unchanged when analysis was restricted to CMML‐1. ASXL1/SRSF2/SF3B1/U2AF1/SETBP1 mutational frequencies were not significantly different between time of CMML diagnosis and BT. Median survival post‐BT was 4.7 months (5‐year survival 6%) and better with allogeneic stem cell transplant (SCT) (14.3 months vs. 4.3 months for chemotherapy vs. 0.9 months for supportive care; P = 0.03). Neither karyotype nor mutational status was independently associated with risk of BT or post‐BT survival. We conclude that female patients with CMML and those with circulating blasts are at a higher risk of BT. Post‐BT survival is dismal and our observations suggest consideration of allogeneic SCT prior to BT.Am. J. Hematol. 90:411–416, 2015. © 2015 Wiley Periodicals, Inc.
Use of Clinical and Electrical Myotonia to Differentiate Childhood Myopathies
Ghosh, Partha S. , Sorenson, Eric J.

Journal of Child Neurology | January 31, 2015 | Volume: 30 | Issue: 10 | Pages: 1300-1306

10.1177/0883073814559646 | PMID 25637645 Get It

We retrospectively reviewed 2030 childhood electromyograms performed over an 11-year period (2004-2014). Twenty children (1%) with myotonic discharges were identified and placed into 2 groups. Group A (electrical and clinical myotonia) comprised 9 children (8 with myotonia congenita and 1 with paramyotonia congenita); all of them had diffuse myotonic discharges without clinical weakness or elevated creatine kinase. Group B (electrical myotonia without clinical myotonia) comprised 11 children (4 with inflammatory myopathy; 3, congenital myopathy, 3, muscular dystrophy; and 1, congenital muscular dystrophy). Clinical weakness was demonstrated in all of them and elevated creatine kinase in 6; all had a myopathic electromyogram and scattered myotonic discharges. We conclude that myotonic discharges are a rare but characteristic spontaneous discharge identified during electrodiagnostic studies in children. The presence of electrical and clinical myotonia provides helpful clues to differentiate between various muscle disorders in children.
A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue
Gilbertson, Janet A. , Theis, Jason D. , Vrana, Julie A. , Lachmann, Helen J. , Wechalekar, Ashutosh , Whelan, Carol , Hawkins, Philip N. , Doǧan, Ahmet , Vrana, Julie A. , Wechalekar, Ashutosh D. , Gillmore, Julian D. , Gillmore, Julian D , Lachmann, Helen

Journal of Clinical Pathology | January 31, 2015 | Volume: 68 | Issue: 4 | Pages: 314-317

10.1136/jclinpath-2014-202722 | PMID 25637636 Get It

Amyloidosis is caused by deposition in tissues of abnormal protein in a characteristic fibrillar form. There are many types of amyloidosis, classified according to the soluble protein precursor from which the amyloid fibrils are derived. Accurate identification of amyloid type is critical in every case since therapy for systemic amyloidosis is type specific. In ∼20–25% cases, however, immunohistochemistry (IHC) fails to prove the amyloid type and further tests are required. Laser microdissection and mass spectrometry (LDMS) is a powerful tool for identifying proteins from formalin-fixed paraffin-embedded tissues. We undertook a blinded comparison of IHC, performed at the UK National Amyloidosis Centre, and LDMS, performed at the Mayo Clinic, in 142 consecutive biopsy specimens from 38 different tissue types. There was 100% concordance between positive IHC and LDMS, and the latter increased diagnostic accuracy from 76% to 94%. LDMS in expert hands is a valuable tool for amyloid diagnosis.
Diagnosis of constrictive pericarditis obscured by hypertrophic cardiomyopathy: Back to basics
Witt, Chance M. , Eleid, Mackram F. , Nishimura, Rick A.

Catheterization and Cardiovascular Interventions | January 30, 2015 | Volume: 86 | Issue: 3 | Pages: 536-539

10.1002/ccd.25873 | PMID 25639819 Get It

In this report, we describe the case of a 41‐year‐old man with hypertrophic cardiomyopathy presenting with right‐sided congestive heart failure symptoms. Noninvasive testing was suggestive, but non‐diagnostic for constrictive pericarditis (CP) and thus invasive hemodynamic catheterization was performed. The unique presence of both hypertrophic cardiomyopathy and constriction in this case led to lack of “modern” echocardiographic and invasive criteria for CP, based upon findings of enhanced ventricular dependence. However, classic hemodynamic criteria of early rapid filling with elevation and end‐equalization of diastolic pressures were present, and the patient ultimately received pericardiectomy with dramatic clinical improvement. © 2015 Wiley Periodicals, Inc.
Faculty Opinions recommendation of Sodium zirconium cyclosilicate in hyperkalemia.
Kashani, Kianoush

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 30, 2015 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.725243590.793503499 Get It

Calcium Channel Blocker Overdose Simulation
Rosa, Delaney La , Simon, Leslie V. , Maniaci, Michael J.

MedEdPORTAL | January 30, 2015 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.15766/mep_2374-8265.10011 Get It

Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid‐induced constipation
Camilleri, Michael , Davies, Andrew , Mawe, Gary M. , Drossman, Douglas A. , Becker, Gerhild , Webster, Lynn Roy

Neurogastroenterology & Motility | January 30, 2015 | Volume: 26 | Issue: 10 | Pages: 1386-1395

10.1111/nmo.12417 | PMID 25164154 Get It

AbstractBackgroundOpioids are effective for acute and chronic pain conditions, but their use is associated with often difficult‐to‐manage constipation and other gastrointestinal (GI) effects due to effects on peripheral μ‐opioid receptors in the gut. The mechanism of opioid‐induced constipation (OIC) differs from that of functional constipation (FC), and OIC may not respond as well to most first‐line treatments for FC. The impact of OIC on quality of life (QoL) induces some patients to decrease or stop their opioid therapy to relieve or avoid constipation.PurposeAt a roundtable meeting on OIC, a working group developed a consensus definition for OIC diagnosis across disciplines and reviewed current OIC treatments and the potential of treatments in development. By consensus, OIC is defined as follows: ‘A change when initiating opioid therapy from baseline bowel habits that is characterized by any of the following: reduced bowel movement frequency, development or worsening of straining to pass bowel movements, a sense of incomplete rectal evacuation, or harder stool consistency’. The working group noted the prior validation of a patient response outcome and end point for clinical trials and recommended future efforts to create treatment guidelines and QoL measures specific for OIC. Details from the working group's discussion and consensus recommendations for patient care and research are presented in this article.
Connections matter − how viruses use cell–cell adhesion components
Mateo, Mathieu , Generous, Alex R., Sinn, Patrick L. , Cattaneo, Roberto , Sinn, Patrick L

Journal of Cell Science | January 30, 2015 | Volume: 128 | Issue: 3 | Pages: 431-439

10.1242/jcs.159400 | PMID 26046138 Get It

ABSTRACT The epithelium is a highly organized type of animal tissue. Except for blood and lymph vessels, epithelial cells cover the body, line its cavities in single or stratified layers and support exchange between compartments. In addition, epithelia offer to the body a barrier to pathogen invasion. To transit through or to replicate in epithelia, viruses have to face several obstacles, starting from cilia and glycocalyx where they can be neutralized by secreted immunoglobulins. Tight junctions and adherens junctions also prevent viruses to cross the epithelial barrier. However, viruses have developed multiple strategies to blaze their path through the epithelium by utilizing components of cell–cell adhesion structures as receptors. In this Commentary, we discuss how viruses take advantage of the apical junction complex to spread. Whereas some viruses quickly disrupt epithelium integrity, others carefully preserve it and use cell adhesion proteins and their cytoskeletal connections to rapidly spread laterally. This is exemplified by the hidden transmission of enveloped viruses that use nectins as receptors. Finally, several viruses that replicate preferentially in cancer cells are currently used as experimental cancer therapeutics. Remarkably, these viruses use cell adhesion molecules as receptors, probably because – to reach tumors and metastases – oncolytic viruses must efficiently traverse or break epithelia.
Quality of life and disease understanding: impact of attending a patient‐centered cancer symposium
Padrnos, Leslie , Dueck, Amylou C. , Scherber, Robyn M. , Glassley, Pamela, Stigge, Rachel, Northfelt, Donald W. , Aguirre, Annette, Scherber, Robyn, Northfelt, Donald, Mıkhael, Joseph , Bennett, Robert M. , Mesa, Ruben A. , Dueck, A. C.

Cancer Medicine | January 30, 2015 | Volume: 4 | Issue: 6 | Pages: 800-807

10.1002/cam4.422 | PMID 25641947 Get It

AbstractTo evaluate the impact of a patient‐centered symposium as an educational intervention on a broad population of cancer patients. We developed a comprehensive patient symposium. Through voluntary questionnaires, we studied the impact of this cancer symposium on quality of life, cancer‐specific knowledge, and symptom management among cancer patients. Symposium attendees were provided surveys prior to and 3 months following the educational intervention. Surveys included (1) EORTC‐QLQ‐C30; (2) disease understanding tool developed for this conference; (3) validated disease‐specific questionnaires. Changes over time were assessed using McNemar's tests and paired t‐tests for categorical and continuous variables, respectively. A total of 158 attendees completed the pre‐convention survey. Most respondents reported at least “quite a bit” of understanding regarding treatment options, screening modalities, symptomatology, and cancer‐related side effects. Attendees endorsed the least understanding of disease‐related stress, risk factors, fatigue management, and legal issues related to disease/treatment. At 3 months, there was improvement in understanding (12 of 14 areas of self‐reported knowledge especially regarding nutrition, and stress/fatigue management). However, no significant change was seen in QLQ‐C30 functioning, fatigue, pain, or insomnia. A patient symposium, as an educational intervention improves a solid knowledge base amongst attendees regarding their disease, increases knowledge in symptom management, but may be insufficient to impact QoL as a single intervention.
Vestibular Function Measurement Devices
Zapala, David A., Miles, Richard D.

Seminars in Hearing | January 29, 2015 | Volume: 36 | Issue: 01 | Pages: 49-74

10.1055/s-0034-1396926 | PMID 27516710 Get It